4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018328
Director acquired 4,746,876 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Bruce Director | 2018-06-25 | Conversion | +4,746,876 | 4,843,625 | I | ||
| Derivatives | |||||||
| Booth Bruce Director | 2018-06-25 | Conversion · Series A Preferred Stock | −12,061,496 | 0 | I | ||
| Booth Bruce Director | 2018-06-25 | Conversion · Series B Preferred Stock | −204,339 | 0 | I | ||
Loading xslF345X03/doc4.xml…